中草药直接抑制2019新型冠状病毒的计算机筛选研究
本研究通过文献检索和分子对接筛选出13种存在于中药中且具有潜在抗2019-nCoV活性的天然化合物,并鉴定出125种含有其中2种及以上化合物的中草药,其中26种在经典本草中记载用于治疗病毒性呼吸道感染。网络药理学预测这些草药的作用与调节病毒感染、免疫/炎症反应和缺氧反应相关。结论认为经典用于治疗病毒性呼吸道感染的中草药可能含有直接抗2019-nCoV的化合物。
要点
- 13种中药天然化合物具有潜在抗2019-nCoV活性。
- 26种经典用于病毒性呼吸道感染的中草药含2种以上上述化合物。
- 网络药理学提示这些草药涉及抗病毒、免疫炎症和缺氧调节。
核心结论
- 经典用于治疗病毒性呼吸道感染的中草药可能含有直接抗2019-nCoV的化合物。
研究设计与样本
- 研究分两步:先文献检索抗SARS-CoV或MERS-CoV的天然化合物,与中药系统药理学数据库交叉核对,经ADME评价和分子对接分析;再检索中草药数据库寻找含有2种及以上筛选化合物的植物,并进行经典本草核对和网络药理学分析。
主要发现
- 筛选出13种存在于中药中且具有潜在抗2019-nCoV活性的天然化合物。
- 发现125种中草药含有2种及以上上述13种化合物。
- 其中26种在经典本草中记载用于治疗病毒性呼吸道感染。
- 网络药理学预测这26种草药的一般体内作用与调节病毒感染、免疫/炎症反应和缺氧反应相关。
临床怎么用
- 对于经典用于病毒性呼吸道感染的中草药,可考虑其含有直接抗2019-nCoV化合物的潜在价值,但需进一步实验验证。
局限性
- 本研究为计算机筛选和网络药理学预测,未进行体外或体内实验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In this study we execute a rational screen to identify Chinese medical herbs that are commonly used in treating viral respiratory infections and also contain compounds that might directly inhibit 2019 novel coronavirus (2019-nCoV), an ongoing novel coronavirus that causes pneumonia. METHODS: There were two main steps in the screening process. In the first step we conducted a literature search for natural compounds that had been biologically confirmed as against sever acute respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus. Resulting compounds were cross-checked for listing in the Traditional Chinese Medicine Systems Pharmacology Database. Compounds meeting both requirements were subjected to absorption, distribution, metabolism and excretion (ADME) evaluation to verify that oral administration would be effective. Next, a docking analysis was used to test whether the compound had the potential for direct 2019-nCoV protein interaction. In the second step we searched Chinese herbal databases to identify plants containing the selected compounds. Plants containing 2 or more of the compounds identified in our screen were then checked against the catalogue for classic herbal usage. Finally, network pharmacology analysis was used to predict the general in vivo effects of each selected herb. RESULTS: Of the natural compounds screened, 13 that exist in traditional Chinese medicines were also found to have potential anti-2019-nCoV activity. Further, 125 Chinese herbs were found to contain 2 or more of these 13 compounds. Of these 125 herbs, 26 are classically catalogued as treating viral respiratory infections. Network pharmacology analysis predicted that the general in vivo roles of these 26 herbal plants were related to regulating viral infection, immune/inflammation reactions and hypoxia response. CONCLUSION: Chinese herbal treatments classically used for treating viral respiratory infection might contain direct anti-2019-nCoV compounds.
引用
- Zhang DH, Wu KL, Zhang X, et al. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. 2020. PMID: 32113846. doi:10.1016/j.joim.2020.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。